Cargando…
lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1
In this study, we examined the clinical significance and molecular mechanisms of a long non-coding RNA (lncRNA), double homeobox A pseudogene 8 (DUXAP8) in hepatocellular carcinoma (HCC). DUXAP8 expression was compared using quantitative real-time PCR in HCC versus adjacent tissues and in HCC cell l...
Autores principales: | Hu, Yu, Zhang, Xian, Zai, Hong-Yan, Jiang, Wei, Xiao, Liang, Zhu, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701012/ https://www.ncbi.nlm.nih.gov/pubmed/33313387 http://dx.doi.org/10.1016/j.omto.2020.10.010 |
Ejemplares similares
-
Downregulated DUXAP8 lncRNA impedes trophoblast cell proliferation and migration by epigenetically upregulating TFPI2 expression
por: Tang, Xiaotong, et al.
Publicado: (2023) -
LncRNA DUXAP8 as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis
por: Wang, Yongfeng, et al.
Publicado: (2022) -
The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer
por: Zhao, Junjie, et al.
Publicado: (2022) -
Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p
por: Liu, Yi, et al.
Publicado: (2021) -
Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers
por: Chen, Jing, et al.
Publicado: (2019)